Status epilepticus

Status asthmaticus SA

Nutritional status

Novartis

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...

Influenza Vaccine Novartis

Novartis on track to resume shipments from troubled Nebraska plant

Novartis expects to resume shipping drugs made at its Nebraska, US plant by the end of the year and is on track to fix other quality issues at Sandoz sites hits with 483s in 2011.

Novartis Delays Restarting Nebraska Factory

The Novartis executive team is learning the hard way the same lesson that the Johnson & Johnson team absorbed earlier this year when trying to convince analysts, investors and customers that a tr...

Novartis to Cut 300 Jobs in OTC Plant Restructuring After Form 483

Novartis says both its Swiss plant and third-parties will support its consumer health lines as it restructures its Nebraska facility following a FDA Form 483.

A Bad Cough: Novartis Recalls More OTC Meds

For the past two years, Novartis has had nothing but problems at a key over-the-counter plant in Lincoln, Nebraska. Manufacturing woes have led to product recalls, lost sales and a managerial shake up...

Novartis OTC Plant Troubled By Quality Failures A Year After Shutdown

FDA recorded nine observations – many of them repeats from 2011 and 2012 – on a form 483 during its early 2013 visit to Novartis Consumer Health’s facility in Lincoln, Nebraska. The observations...

Novartis' lung cancer drug gets breakthrough designation

The FDA granted breakthrough therapy status to Novartis' LDK378 for treatment of patients with anaplastic lymphoma kinase pos -More- 

Status Of Ranbaxy’s First Filer Status For Dioxan Remains A Mystery After Judge Tosses Mylan Lawsuit

Court says FDA handled changed USP monograph appropriately, but ruling sheds no new light on the status of first-filer Ranbaxy’s tentatively approved valsartan ANDA or when the first generic version...

Be Healthy is an internal initiative for the benefit of Novartis associates.

Joseph Jimenez, CEO of Novartis, talks about how Novartis Group Company associates across 32 countries are participating in a new Novartis health and well-being initiative during the first Novartis Be...

The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease.

Invasive nontyphoidal Salmonella disease in Africa: current status.

Spintronics: Electric toggling of magnets.

Allosteric modulators of the calcium-sensing receptor: turning news into distinct views.

Editorial: Peer across the barrier--new live transmissions from the intestinal mucosa.